|
| Status |
Public on Jul 27, 2022 |
| Title |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
36109558 |
| |
| Submission date |
Nov 21, 2021 |
| Last update date |
Sep 27, 2022 |
| Contact name |
Masanori Fujimoto |
| E-mail(s) |
fujimoto212@gmail.com
|
| Organization name |
Chiba University
|
| Department |
Graduate School of Medicine
|
| Lab |
1. Department of Molecular Diagnosis, 2. Department of Endocrinology, Hematology and Gerontology
|
| Street address |
Inohana 1-8-1
|
| City |
Chiba-city |
| State/province |
Chiba-prefecture |
| ZIP/Postal code |
260-8677 |
| Country |
Japan |
| |
|
| Platforms (3) |
| GPL18480 |
Illumina HiSeq 1500 (Mus musculus) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (30)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE189282 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [bulkRNA-seq_Hepatocyte] |
| GSE189283 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [ATAC-Seq] |
| GSE189284 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [ChIP-Seq] |
| GSE189285 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_ILC2] |
| GSE189286 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_Hepatocyte] |
|
| Relations |
| BioProject |
PRJNA782343 |
Less...
More...